Why do women doctors in the UK take hormone replacement therapy?

STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of epidemiology and community health (1979) 1997-08, Vol.51 (4), p.373-377
Hauptverfasser: Isaacs, A J, Britton, A R, McPherson, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 377
container_issue 4
container_start_page 373
container_title Journal of epidemiology and community health (1979)
container_volume 51
creator Isaacs, A J
Britton, A R
McPherson, K
description STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects. CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.
doi_str_mv 10.1136/jech.51.4.373
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1060503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25568499</jstor_id><sourcerecordid>25568499</sourcerecordid><originalsourceid>FETCH-LOGICAL-b630t-49ee8107ef1f85f02fa4ef54cd9c1f99cd984024af335b6dff5928ef239757d03</originalsourceid><addsrcrecordid>eNqFkUGP0zAQhS0EWsrCkSNSJNDCJcWO7Ux8gUUVuyCW5cKyiIvlOmOabBIXOwX673HVqgUOIFkaS-_T05t5hDxkdMoYL5-3aBdTyaZiyoHfIhMmgOYF8Oo2mVAmeE6p_HyX3IuxpekLhToiR4oXlRRsQk6vF-us9tkP3-OQPnb0IWbNkI0LzK7eZaO5wWzhQ-8HzAIuO2MxkeNGD2a5fnmf3HGmi_hgN4_J1dnrj7M3-cWH87ezVxf5vOR0zIVCrBgFdMxV0tHCGYFOClsry5xSaVaCFsI4zuW8rJ2TqqjQFVyBhJryY_Ji67tczXusbcoQTKeXoelNWGtvGv2nMjQL_dV_14yWVFKeDE52BsF_W2Ecdd9Ei11nBvSrqCHdRACXCXz6b7BMQalSkMjHf5GtX4UhnUEzAFGK9DZ--ZaywccY0O1DM6o3FepNhVoyLXSqMPGPft90T-86S_qTnW6iNZ0LZrBN3GMFqBIKONi0MXV6kKUsK6HUIVYTR_y510240SVwkPry00yfnQOo95df9HXin235ed_-Z4NfzrTJdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1774644645</pqid></control><display><type>article</type><title>Why do women doctors in the UK take hormone replacement therapy?</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Isaacs, A J ; Britton, A R ; McPherson, K</creator><creatorcontrib>Isaacs, A J ; Britton, A R ; McPherson, K</creatorcontrib><description>STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects. CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.</description><identifier>ISSN: 0143-005X</identifier><identifier>EISSN: 1470-2738</identifier><identifier>DOI: 10.1136/jech.51.4.373</identifier><identifier>PMID: 9328541</identifier><identifier>CODEN: JECHDR</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>Attitude of Health Personnel ; Biological and medical sciences ; Breast cancer ; Cardiovascular diseases ; Contraception ; Coronary Disease - prevention &amp; control ; Estrogen Replacement Therapy - psychology ; Estrogen Replacement Therapy - statistics &amp; numerical data ; Female ; Genetics ; Health Services Research ; Hormone replacement therapy ; Hormones. Endocrine system ; Humans ; Life Style ; Medical sciences ; Menopause ; Middle Aged ; Osteoporosis ; Osteoporosis, Postmenopausal - prevention &amp; control ; Pharmacology. Drug treatments ; Physicians, Women - psychology ; Physicians, Women - statistics &amp; numerical data ; Postmenopause ; Prevention ; Random Allocation ; Side effects ; Surveys and Questionnaires ; Symptoms ; Time Factors ; Womens health</subject><ispartof>Journal of epidemiology and community health (1979), 1997-08, Vol.51 (4), p.373-377</ispartof><rights>Copyright 1997 The Journal of Epidemiology and Community Health</rights><rights>1997 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Aug 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b630t-49ee8107ef1f85f02fa4ef54cd9c1f99cd984024af335b6dff5928ef239757d03</citedby><cites>FETCH-LOGICAL-b630t-49ee8107ef1f85f02fa4ef54cd9c1f99cd984024af335b6dff5928ef239757d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25568499$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25568499$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27924,27925,53791,53793,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2796727$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9328541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Isaacs, A J</creatorcontrib><creatorcontrib>Britton, A R</creatorcontrib><creatorcontrib>McPherson, K</creatorcontrib><title>Why do women doctors in the UK take hormone replacement therapy?</title><title>Journal of epidemiology and community health (1979)</title><addtitle>J Epidemiol Community Health</addtitle><description>STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects. CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.</description><subject>Attitude of Health Personnel</subject><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Cardiovascular diseases</subject><subject>Contraception</subject><subject>Coronary Disease - prevention &amp; control</subject><subject>Estrogen Replacement Therapy - psychology</subject><subject>Estrogen Replacement Therapy - statistics &amp; numerical data</subject><subject>Female</subject><subject>Genetics</subject><subject>Health Services Research</subject><subject>Hormone replacement therapy</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Life Style</subject><subject>Medical sciences</subject><subject>Menopause</subject><subject>Middle Aged</subject><subject>Osteoporosis</subject><subject>Osteoporosis, Postmenopausal - prevention &amp; control</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicians, Women - psychology</subject><subject>Physicians, Women - statistics &amp; numerical data</subject><subject>Postmenopause</subject><subject>Prevention</subject><subject>Random Allocation</subject><subject>Side effects</subject><subject>Surveys and Questionnaires</subject><subject>Symptoms</subject><subject>Time Factors</subject><subject>Womens health</subject><issn>0143-005X</issn><issn>1470-2738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkUGP0zAQhS0EWsrCkSNSJNDCJcWO7Ux8gUUVuyCW5cKyiIvlOmOabBIXOwX673HVqgUOIFkaS-_T05t5hDxkdMoYL5-3aBdTyaZiyoHfIhMmgOYF8Oo2mVAmeE6p_HyX3IuxpekLhToiR4oXlRRsQk6vF-us9tkP3-OQPnb0IWbNkI0LzK7eZaO5wWzhQ-8HzAIuO2MxkeNGD2a5fnmf3HGmi_hgN4_J1dnrj7M3-cWH87ezVxf5vOR0zIVCrBgFdMxV0tHCGYFOClsry5xSaVaCFsI4zuW8rJ2TqqjQFVyBhJryY_Ji67tczXusbcoQTKeXoelNWGtvGv2nMjQL_dV_14yWVFKeDE52BsF_W2Ecdd9Ei11nBvSrqCHdRACXCXz6b7BMQalSkMjHf5GtX4UhnUEzAFGK9DZ--ZaywccY0O1DM6o3FepNhVoyLXSqMPGPft90T-86S_qTnW6iNZ0LZrBN3GMFqBIKONi0MXV6kKUsK6HUIVYTR_y510240SVwkPry00yfnQOo95df9HXin235ed_-Z4NfzrTJdg</recordid><startdate>19970801</startdate><enddate>19970801</enddate><creator>Isaacs, A J</creator><creator>Britton, A R</creator><creator>McPherson, K</creator><general>BMJ Publishing Group Ltd</general><general>British Medical Association</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970801</creationdate><title>Why do women doctors in the UK take hormone replacement therapy?</title><author>Isaacs, A J ; Britton, A R ; McPherson, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b630t-49ee8107ef1f85f02fa4ef54cd9c1f99cd984024af335b6dff5928ef239757d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Attitude of Health Personnel</topic><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Cardiovascular diseases</topic><topic>Contraception</topic><topic>Coronary Disease - prevention &amp; control</topic><topic>Estrogen Replacement Therapy - psychology</topic><topic>Estrogen Replacement Therapy - statistics &amp; numerical data</topic><topic>Female</topic><topic>Genetics</topic><topic>Health Services Research</topic><topic>Hormone replacement therapy</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Life Style</topic><topic>Medical sciences</topic><topic>Menopause</topic><topic>Middle Aged</topic><topic>Osteoporosis</topic><topic>Osteoporosis, Postmenopausal - prevention &amp; control</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicians, Women - psychology</topic><topic>Physicians, Women - statistics &amp; numerical data</topic><topic>Postmenopause</topic><topic>Prevention</topic><topic>Random Allocation</topic><topic>Side effects</topic><topic>Surveys and Questionnaires</topic><topic>Symptoms</topic><topic>Time Factors</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Isaacs, A J</creatorcontrib><creatorcontrib>Britton, A R</creatorcontrib><creatorcontrib>McPherson, K</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of epidemiology and community health (1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Isaacs, A J</au><au>Britton, A R</au><au>McPherson, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Why do women doctors in the UK take hormone replacement therapy?</atitle><jtitle>Journal of epidemiology and community health (1979)</jtitle><addtitle>J Epidemiol Community Health</addtitle><date>1997-08-01</date><risdate>1997</risdate><volume>51</volume><issue>4</issue><spage>373</spage><epage>377</epage><pages>373-377</pages><issn>0143-005X</issn><eissn>1470-2738</eissn><coden>JECHDR</coden><abstract>STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects. CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>9328541</pmid><doi>10.1136/jech.51.4.373</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0143-005X
ispartof Journal of epidemiology and community health (1979), 1997-08, Vol.51 (4), p.373-377
issn 0143-005X
1470-2738
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1060503
source MEDLINE; JSTOR Archive Collection A-Z Listing; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Attitude of Health Personnel
Biological and medical sciences
Breast cancer
Cardiovascular diseases
Contraception
Coronary Disease - prevention & control
Estrogen Replacement Therapy - psychology
Estrogen Replacement Therapy - statistics & numerical data
Female
Genetics
Health Services Research
Hormone replacement therapy
Hormones. Endocrine system
Humans
Life Style
Medical sciences
Menopause
Middle Aged
Osteoporosis
Osteoporosis, Postmenopausal - prevention & control
Pharmacology. Drug treatments
Physicians, Women - psychology
Physicians, Women - statistics & numerical data
Postmenopause
Prevention
Random Allocation
Side effects
Surveys and Questionnaires
Symptoms
Time Factors
Womens health
title Why do women doctors in the UK take hormone replacement therapy?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Why%20do%20women%20doctors%20in%20the%20UK%20take%20hormone%20replacement%20therapy?&rft.jtitle=Journal%20of%20epidemiology%20and%20community%20health%20(1979)&rft.au=Isaacs,%20A%20J&rft.date=1997-08-01&rft.volume=51&rft.issue=4&rft.spage=373&rft.epage=377&rft.pages=373-377&rft.issn=0143-005X&rft.eissn=1470-2738&rft.coden=JECHDR&rft_id=info:doi/10.1136/jech.51.4.373&rft_dat=%3Cjstor_pubme%3E25568499%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1774644645&rft_id=info:pmid/9328541&rft_jstor_id=25568499&rfr_iscdi=true